Yifan Pharmaceutical Co Ltd
SZSE:002019
Yifan Pharmaceutical Co Ltd
Operating Expenses
Yifan Pharmaceutical Co Ltd
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Y
|
Yifan Pharmaceutical Co Ltd
SZSE:002019
|
Operating Expenses
-¥2.8B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-28%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Operating Expenses
-¥14.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-25%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Expenses
-¥6.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Expenses
-¥1.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-17%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Expenses
-¥14.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-15%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Expenses
-¥6.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-12%
|
See Also
What is Yifan Pharmaceutical Co Ltd's Operating Expenses?
Operating Expenses
-2.8B
CNY
Based on the financial report for Mar 31, 2024, Yifan Pharmaceutical Co Ltd's Operating Expenses amounts to -2.8B CNY.
What is Yifan Pharmaceutical Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-28%
Over the last year, the Operating Expenses growth was -62%. The average annual Operating Expenses growth rates for Yifan Pharmaceutical Co Ltd have been -28% over the past three years , -20% over the past five years , and -28% over the past ten years .